Barclays Downgrades Doximity (NYSE:DOCS) to Hold

Doximity (NYSE:DOCS) was downgraded by equities research analysts at Barclays from a “strong-buy” rating to a “hold” rating in a research note issued on Thursday,Zacks.com reports.

A number of other research firms have also recently weighed in on DOCS. Zacks Research raised Doximity from a “strong sell” rating to a “hold” rating in a research report on Tuesday, April 21st. Loop Capital set a $31.00 price objective on Doximity in a research report on Tuesday, March 17th. Evercore cut Doximity from an “outperform” rating to an “in-line” rating and set a $25.00 price objective for the company. in a research report on Wednesday, April 8th. Truist Financial reissued a “hold” rating and issued a $19.00 price objective (down from $29.00) on shares of Doximity in a research report on Thursday. Finally, Leerink Partners lowered their price objective on Doximity from $31.00 to $25.00 and set an “outperform” rating for the company in a research report on Thursday. Two equities research analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating and fourteen have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $30.62.

Doximity Price Performance

Doximity stock opened at $18.93 on Thursday. The firm has a market cap of $3.50 billion, a PE ratio of 19.12, a price-to-earnings-growth ratio of 1.28 and a beta of 1.36. Doximity has a 1-year low of $17.15 and a 1-year high of $76.51. The stock has a fifty day simple moving average of $23.94.

Doximity declared that its board has authorized a share buyback plan on Thursday, February 5th that authorizes the company to buyback $500.00 million in shares. This buyback authorization authorizes the company to buy up to 8% of its stock through open market purchases. Stock buyback plans are generally a sign that the company’s board believes its stock is undervalued.

Insider Transactions at Doximity

In other Doximity news, Director Kira Scherer Wampler sold 9,000 shares of Doximity stock in a transaction dated Thursday, May 7th. The stock was sold at an average price of $26.06, for a total transaction of $234,540.00. Following the completion of the transaction, the director owned 19,839 shares in the company, valued at approximately $517,004.34. This trade represents a 31.21% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Siddharth Sitaram sold 2,427 shares of Doximity stock in a transaction dated Friday, April 10th. The shares were sold at an average price of $21.09, for a total value of $51,185.43. Following the transaction, the insider owned 86,705 shares of the company’s stock, valued at $1,828,608.45. The trade was a 2.72% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 18,055 shares of company stock valued at $456,061 in the last quarter. Company insiders own 31.30% of the company’s stock.

Hedge Funds Weigh In On Doximity

Institutional investors have recently modified their holdings of the stock. Root Financial Partners LLC purchased a new position in shares of Doximity during the 3rd quarter valued at about $30,000. Whittier Trust Co. of Nevada Inc. raised its stake in shares of Doximity by 59.5% during the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 480 shares of the company’s stock valued at $35,000 after buying an additional 179 shares during the last quarter. Atlantic Union Bankshares Corp raised its stake in shares of Doximity by 136.9% during the 3rd quarter. Atlantic Union Bankshares Corp now owns 616 shares of the company’s stock valued at $45,000 after buying an additional 356 shares during the last quarter. First Horizon Corp purchased a new position in shares of Doximity during the 3rd quarter valued at about $58,000. Finally, Northwestern Mutual Wealth Management Co. increased its stake in shares of Doximity by 99.5% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 796 shares of the company’s stock valued at $35,000 after purchasing an additional 397 shares in the last quarter. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Key Stories Impacting Doximity

Here are the key news stories impacting Doximity this week:

• Positive Sentiment: Doximity said revenue still grew year over year, and its earnings call highlighted strong engagement from AI tool adoption, suggesting the platform is gaining traction with physicians. Doximity Stock Falls on Q4 Earnings Miss, Revenues Beat, Margins Down
• Positive Sentiment: Doximity announced a partnership with Aledade to bring clinical AI tools into value-based care workflows, which could support longer-term adoption and monetization. DOCS Teams Up With Aledade to Bring Clinical AI to Value-Based Care
• Neutral Sentiment: Several articles noted the stock has become technically oversold after a sharp selloff, which could set up a bounce if sentiment improves. Down 25.7% in 4 Weeks, Here’s Why Doximity (DOCS) Looks Ripe for a Turnaround
• Negative Sentiment: Doximity missed quarterly earnings estimates and issued fiscal 2027 revenue guidance below Wall Street expectations, raising concerns that growth is slowing. Doximity, Inc. (DOCS) Q4 2026 Earnings Call Transcript
• Negative Sentiment: Analysts turned more cautious, with multiple firms cutting price targets or downgrading the stock, including Baird, Wells Fargo, BTIG, JPMorgan, Mizuho, BMO, Needham and Truist. DOCS vs. HIMS: Which Stock Is the Better Value Option?
• Negative Sentiment: Investor caution also increased after insider selling was disclosed, even though it was tied to a pre-arranged 10b5-1 plan and tax withholding. Doximity (NYSE:DOCS) Insider Siddharth Sitaram Sells 2,309 Shares

About Doximity

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.